SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-16-079268
Filing Date
2016-02-05
Accepted
2016-02-05 15:48:11
Documents
1
Group Members
FORESITE CAPITAL FUND III, L.P.FORESITE CAPITAL MANAGEMENT II, LLCFORESITE CAPITAL MANAGEMENT III, LLCJAMES TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v430587_sc13ga.htm SC 13G/A 82761
  Complete submission text file 0001144204-16-079268.txt   84476
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Subject) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87002 | Film No.: 161392085
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 CALIFORNIA STREET, SUITE 4100 SAN FRANCISCO CA 94111
Business Address 101 CALIFORNIA STREET, SUITE 4100 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund II, L.P. (Filed by) CIK: 0001594914 (see all company filings)

IRS No.: 901029166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A